CRYSTAL LAKE, Ill.– Aptar Digital Health, a global leader in digital health solutions including Software as a Medical Device (SaMD), digital Patient Support Programs, connected devices, and disease management platforms, today announced a collaboration with Guy’s and St Thomas’ NHS Foundation Trust, a leading Trust in London, United Kingdom, to evaluate the impact of Aptar Digital Health’s Respiratory Disease Management Platform, ADH Respiratory DMP, on asthma patients. Both organizations are partnering with the Clinical Research Organization (CRO) Lindus Health to execute the study.
The clinical study, which began in July 2024 and will run for twelve months, will recruit 118 adults with moderate to severe asthma, with the primary aim of assessing the improvement of asthma symptom control.
During the study, clinical data, including asthma control symptoms, quality of life, asthma controller medication adherence, healthcare resource utilization and overall satisfaction with the digital solution, will be evaluated.
